Pharma funds offered negative returns in 2022. Will they do well this year?
In 2022, pharma funds lost 9.68%. All the schemes in this category delivered negative returns last year. The underperformance is in line with benchmark Nifty Pharma index, which was down over 10.60% in 2022.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
